Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry G M Heijerman

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Therapeutic Drug Monitoring|February 13, 2020
Does Circadian Rhythm Affect the Pharmacokinetics of Once-Daily Tobramycin in Adults With Cystic Fibrosis?Erik M van Maarseveen, Renske van der Meer, Cees Neef, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2007
Pharmacokinetics of aztreonam in healthy subjects and patients with cystic fibrosis and evaluation of dose-exposure relationships using monte carlo simulationAlexander A Vinks, Ronald N van Rossem, Ron A A Mathôt, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Nutrition in patients with cystic fibrosis: a European ConsensusM Sinaasappel, M Stern, J Littlewood, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 16, 2022
Development and outcomes of a patient driven cystic fibrosis quality of care improvement projectJacquelien J Noordhoek, Joshena Jeyaratnam, Domenique Zomer, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 16, 2008
Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD)Johanna M W van den Berg, Alison M Morton, Simon W Kok, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 3, 2006
Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder dosesAnne H de Boer, Paul Hagedoorn, Elsbeth M Westerman, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|May 27, 2009
Changes in performance of the Pari eFlow rapid and Pari LC Plus during 6 months use by CF patientsBart L Rottier, Cyril J P van Erp, Tanya S Sluyter, et al.
The Laryngoscope|December 31, 2013
Temporal bone pneumatization in cystic fibrosis: a correlation with genotype?Maaike C Berkhout, Cornelis J van Rooden, Ralph C Aalbers, et al.
Chest|October 21, 2005
Birth prevalence and survival in cystic fibrosis: a national cohort study in the NetherlandsMartijn G Slieker, Cuno S P M Uiterwaal, Maarten Sinaasappel, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 10, 2022
The influence of exocrine pancreatic function on the exposure and pharmacokinetics of ivacaftor in people with cystic fibrosisRenske van der Meer, Erik B Wilms, Margot N Eggermont, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Therapeutic Drug Monitoring|February 13, 2020
Does Circadian Rhythm Affect the Pharmacokinetics of Once-Daily Tobramycin in Adults With Cystic Fibrosis?Erik M van Maarseveen, Renske van der Meer, Cees Neef, et al.
Antimicrobial Agents and Chemotherapy|June 20, 2007
Pharmacokinetics of aztreonam in healthy subjects and patients with cystic fibrosis and evaluation of dose-exposure relationships using monte carlo simulationAlexander A Vinks, Ronald N van Rossem, Ron A A Mathôt, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Nutrition in patients with cystic fibrosis: a European ConsensusM Sinaasappel, M Stern, J Littlewood, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 16, 2022
Development and outcomes of a patient driven cystic fibrosis quality of care improvement projectJacquelien J Noordhoek, Joshena Jeyaratnam, Domenique Zomer, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 16, 2008
Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD)Johanna M W van den Berg, Alison M Morton, Simon W Kok, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 3, 2006
Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder dosesAnne H de Boer, Paul Hagedoorn, Elsbeth M Westerman, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|May 27, 2009
Changes in performance of the Pari eFlow rapid and Pari LC Plus during 6 months use by CF patientsBart L Rottier, Cyril J P van Erp, Tanya S Sluyter, et al.
The Laryngoscope|December 31, 2013
Temporal bone pneumatization in cystic fibrosis: a correlation with genotype?Maaike C Berkhout, Cornelis J van Rooden, Ralph C Aalbers, et al.
Chest|October 21, 2005
Birth prevalence and survival in cystic fibrosis: a national cohort study in the NetherlandsMartijn G Slieker, Cuno S P M Uiterwaal, Maarten Sinaasappel, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 10, 2022
The influence of exocrine pancreatic function on the exposure and pharmacokinetics of ivacaftor in people with cystic fibrosisRenske van der Meer, Erik B Wilms, Margot N Eggermont, et al.
Pageof 5